blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3800203

EP3800203 - MULTISPECIFIC BINDING PROTEINS TARGETING CAIX, ANO1, MESOTHELIN,TROP2, CEA, OR CLAUDIN-18.2 [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  15.10.2021
Database last updated on 02.09.2024
FormerThe application has been published
Status updated on  05.03.2021
Most recent event   Tooltip24.05.2024Change - applicantpublished on 26.06.2024  [2024/26]
Applicant(s)For all designated states
Dragonfly Therapeutics, Inc.
180 3rd Avenue, Sixth Floor
Waltham, MA 02451 / US
[2024/26]
Former [2021/14]For all designated states
Dragonfly Therapeutics, Inc.
35 Gatehouse Drive
Waltham, MA 02451 / US
Inventor(s)01 / CHANG, Gregory, P.
143 Saunders Street
Medford, MA 02155 / US
02 / CHEUNG, Ann, F.
25 Morningside Lane
Lincoln, MA 01773 / US
03 / GUTIERREZ, Eva
67 Hillcrest Street
Waltham, MA 02451 / US
04 / HANEY, William
61 Lincoln Road
Wayland, MA 01778 / US
05 / LUNDE, Bradley, M.
7 Lucent Drive
Lebanon, NH 03766 / US
06 / PRINZ, Bianka
7 Lucent Drive
Lebanon, NH 03766 / US
 [2021/14]
Representative(s)Haseltine Lake Kempner LLP
Cheapside House
138 Cheapside
London EC2V 6BJ / GB
[N/P]
Former [2021/14]Haseltine Lake Kempner LLP
Cheapside House
138 Cheapside
London
EC2V 6BJ / GB
Application number, filing date20207020.727.02.2018
[2021/14]
Priority number, dateUS201762464347P27.02.2017         Original published format: US 201762464347 P
US201762464344P27.02.2017         Original published format: US 201762464344 P
US201762464341P27.02.2017         Original published format: US 201762464341 P
US201762467557P06.03.2017         Original published format: US 201762467557 P
US201762473652P20.03.2017         Original published format: US 201762473652 P
US201762473659P20.03.2017         Original published format: US 201762473659 P
[2021/14]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3800203
Date:07.04.2021
Language:EN
[2021/14]
Search report(s)(Supplementary) European search report - dispatched on:EP04.03.2021
ClassificationIPC:C07K16/30, C07K16/28, A61K39/00, A61K39/395, A61P35/00, C07K16/46, C07K16/40
[2021/14]
CPC:
A61P35/00 (EP,KR,US); C07K16/2851 (EP,KR,US); C07K16/18 (US);
C07K16/28 (KR,US); C07K16/2803 (EP); C07K16/283 (EP,KR,US);
C07K16/30 (EP,KR,US); C07K16/3007 (EP,KR); C07K16/40 (EP,KR,US);
C07K16/46 (US); A61K2039/505 (KR); C07K2317/31 (EP,KR,US);
C07K2317/33 (EP); C07K2317/524 (US); C07K2317/53 (US);
C07K2317/55 (EP); C07K2317/565 (US); C07K2317/569 (US);
C07K2317/60 (EP); C07K2317/73 (EP,US); C07K2317/75 (EP);
C07K2317/76 (US); C07K2317/92 (EP); C07K2317/94 (EP,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2021/46]
Former [2021/14]AL,  AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  RS,  SE,  SI,  SK,  SM,  TR 
TitleGerman:MULTISPEZIFISCHE BINDUNGSPROTEINE MIT TARGETING VON CAIX, ANO1, MESOTHELIN,TROP2, CEA ODER CLAUDIN-18.2[2021/14]
English:MULTISPECIFIC BINDING PROTEINS TARGETING CAIX, ANO1, MESOTHELIN,TROP2, CEA, OR CLAUDIN-18.2[2021/14]
French:PROTÉINES DE LIAISON MULTI-SPÉCIFIQUES CIBLANT CAIX, ANO1, LA MÉSOTHÉLINE, TROP2, CEA OU LA CLAUDINE-18.2[2021/14]
Examination procedure07.10.2021Amendment by applicant (claims and/or description)
07.10.2021Examination requested  [2021/46]
07.10.2021Date on which the examining division has become responsible
Parent application(s)   TooltipEP18756655.9  / EP3585424
Fees paidRenewal fee
11.11.2020Renewal fee patent year 03
27.04.2021Renewal fee patent year 04
25.02.2022Renewal fee patent year 05
27.02.2023Renewal fee patent year 06
27.02.2024Renewal fee patent year 07
Penalty fee
Additional fee for renewal fee
28.02.202104   M06   Fee paid on   27.04.2021
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[I]WO2016115274  (COMPASS THERAPEUTICS LLC [US], et al);
by applicantUS7879985
 WO2015095412
 US9273136
 WO2016134371
 US20090811207
 US20090533709
 US20100875015
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.